Companies can now apply for authorisation to produce cannabis bulk and cannabis primary products

21 August 2018

On 1 July 2018, a new executive order entered into force which gives companies the possibility of cultivating cannabis for medicinal use and producing cannabis bulk and cannabis primary products from Danish-grown cannabis.

The new rules are introduced as part of the four-year medicinal cannabis pilot programme, which was launched on 1 January 2018.

The application material for cultivation of cannabis for medicinal use and production of cannabis bulk and cannabis primary products from Danish-grown cannabis is available on the website of the Danish Medicines Agency:

Application material for production of cannabis intermediate products

Application material for production of cannabis bulk 

 

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.